GlobeNewswire Inc.··NaPrecipio Posts 30% Revenue Growth; Partners with Memorial Sloan-Kettering on Cancer Test
Cancer diagnostics firm $PRPO reports $24M in 2025 revenues, up 30% year-over-year, and publishes peer-reviewed study on its BCR::ABL1 blood test.
PRPOQ4 2025 earningsrevenue growth